Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device aims to stop bulging blood vessels from growing

NCT ID NCT05133492

First seen Jan 10, 2026 · Last updated May 21, 2026 · Updated 14 times

Summary

This early study tests a new device called the Nectero EAST System in 46 people with abdominal aortic aneurysms (AAA) — a bulging blood vessel in the belly. The device delivers a special compound into the aneurysm sac to keep it from growing larger. The main goals are to check safety and see if the device can be delivered successfully, with follow-up over 36 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Auckland City Hospital

    Auckland, New Zealand

  • Pablo Tabon Uribe Hospital

    Medellín, Antioquia, Colombia

  • Pauls Stradins Clinical University Hospital

    Riga, Latvia

  • Prince of Wales Private Hospital

    Randwick, New South Wales, 2031, Australia

  • Queen Mary Hospital

    Hong Kong, Southern District, China

Conditions

Explore the condition pages connected to this study.